Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Unique features of alloreactivity
- Estimating frequency of alloreactive T cells in vivo
- Alloreactive precursor frequency
- Tolerance approaches
- T cells costimulatory pathways
- Blockade induces transplant tolerance
- Distinct effects of CD28 costimulation
- Apoptotic T cells induce transplantation tolerance
- Calcineurin inhibition antagonizes blockade
- Antagonism of blockade and calcineurin inhibitors
- Reduction in T cells number facilitates tolerance
- How to delete alloreactive cells?
- Homeostatic proliferation
- Homeostatic proliferation: a barrier to tolerance
- Homeostatic proliferation and memory generation
- Memory-like functional responses
- Memory T cells abrogate graft prolongation
- Cardiac allograft rejection in scid mice
- Scid mice resist tolerance induction
- Homeostatic proliferation of B6 T cells
- T cells depletion leads to proliferation (1)
- T cells depletion leads to proliferation (2)
- Incomplete T cells depletion affects tolerance
- Do memory cells develop due to failure to tolerize?
- BrdU incorporation in transferred B6 T cells
- Cardiac allograft rejection
- Failure to maintain suppressor cells
- % of CD4+CD25+ after homeostatic proliferation
- T cells from reconstituted scid mice
- Reconstituting normal mice made T-cell deficient
- Failure to tolerize after homeostatic proliferation
- Reduction in clonal mass facilitates tolerance
- Heterologous immunity: a barrier to tolerance (1)
- Heterologous immunity: a barrier to tolerance (2)
- Memory cells in partial depletion, lymphopenia
- Various types of cells in the aftermath of depletion
- Differential depletion
- Sparing of memory T cells after depletion
- Differential proliferation
- Testing differential proliferation
- Proliferation of memory T cells after depletion (1)
- Proliferation of memory T cells after depletion (2)
- Depletion doesn't alter the proportion of CD4 cells
- CD4+CD25+ Tregs versus non-regulatory T cells
- Prevention of rejection of homeostatic proliferation
- Restoring tolerance induction by Tregs
- Restoring tolerance induction by anti-CD4/CD8
- Anti-CD4/CD8 block homeostatic proliferation
- Why is transplant tolerance hard to achieve?
- Acknowledgements
Topics Covered
- Overview of alloreactivity
- Tolerance approaches
- Co-stimulatory blockade
- Requirement for cell depletion
- Homeostatic proliferation overview
- Homeostatic proliferation generates memory cells and blocks tolerance induction
- Depletion spares memory cells
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Turka, L. (2007, October 1). Antibody depletion therapy in transplantation: implications for tolerance [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/NEPF3205.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Laurence Turka has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Antibody depletion therapy in transplantation: implications for tolerance
A selection of talks on Methods
Hide